<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>dofetilide</title><link>http://www.unboundmedicine.com/medline/ebm/research/dofetilide</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19819878/full_citation/Dofetilide_is_safe_and_effective_in_preventing_atrial_fibrillation_recurrences_in_patients_accepted_for_catheter_ablation_</link><description>Shamiss Y, Khaykin Y, Oosthuizen R, et al. <br/><span class="title">Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology">Europace 2009 Oct 8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19819878/abstract/Dofetilide_is_safe_and_effective_in_preventing_atrial_fibrillation_recurrences_in_patients_accepted_for_catheter_ablation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19819878/full_citation/Dofetilide_is_safe_and_effective_in_preventing_atrial_fibrillation_recurrences_in_patients_accepted_for_catheter_ablation_">Full Citation</a></description></item><item><title>Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19808490/full_citation/Treatment_of_atrial_fibrillation_with_antiarrhythmic_drugs_or_radiofrequency_ablation:_two_systematic_literature_reviews_and_meta_analyses_</link><description>Calkins H, Reynolds MR, Spector P, et al. <br/><span class="title">Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Circulation. Arrhythmia and electrophysiology">Circ Arrhythm Electrophysiol 2009 Aug; 2(4):349-61.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19808490/abstract/Treatment_of_atrial_fibrillation_with_antiarrhythmic_drugs_or_radiofrequency_ablation:_two_systematic_literature_reviews_and_meta_analyses_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19808490/full_citation/Treatment_of_atrial_fibrillation_with_antiarrhythmic_drugs_or_radiofrequency_ablation:_two_systematic_literature_reviews_and_meta_analyses_">Full Citation</a></description></item><item><title>Inhibition of I(K,ACh) current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19760273/full_citation/Inhibition_of_I_KACh__current_may_contribute_to_clinical_efficacy_of_class_I_and_class_III_antiarrhythmic_drugs_in_patients_with_atrial_fibrillation_</link><description>Voigt N, Rozmaritsa N, Trausch A, et al. <br/><span class="title">Inhibition of I(K,ACh) current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Naunyn-Schmiedeberg's archives of pharmacology">Naunyn Schmiedebergs Arch Pharmacol 2009 Sep 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19760273/abstract/Inhibition_of_I_KACh__current_may_contribute_to_clinical_efficacy_of_class_I_and_class_III_antiarrhythmic_drugs_in_patients_with_atrial_fibrillation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19760273/full_citation/Inhibition_of_I_KACh__current_may_contribute_to_clinical_efficacy_of_class_I_and_class_III_antiarrhythmic_drugs_in_patients_with_atrial_fibrillation_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19760273/Inhibition_of_I_KACh__current_may_contribute_to_clinical_efficacy_of_class_I_and_class_III_antiarrhythmic_drugs_in_patients_with_atrial_fibrillation_">Find Related Articles</a> </description></item><item><title>I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19744496/full_citation/I_Ks__restricts_excessive_beat_to_beat_variability_of_repolarization_during_beta_adrenergic_receptor_stimulation_</link><description>Johnson DM, Heijman J, Pollard CE, et al. <br/><span class="title">I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of molecular and cellular cardiology">J Mol Cell Cardiol 2009 Sep 7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19744496/abstract/I_Ks__restricts_excessive_beat_to_beat_variability_of_repolarization_during_beta_adrenergic_receptor_stimulation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19744496/full_citation/I_Ks__restricts_excessive_beat_to_beat_variability_of_repolarization_during_beta_adrenergic_receptor_stimulation_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-2828(09)00376-9">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19744496/I_Ks__restricts_excessive_beat_to_beat_variability_of_repolarization_during_beta_adrenergic_receptor_stimulation_">Find Related Articles</a> </description></item><item><title>Exploring Chemical Substructures Essential for hERG K(+) Channel Blockade by Synthesis and Biological Evaluation of Dofetilide Analogues.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19725081/full_citation/Exploring_Chemical_Substructures_Essential_for_hERG_K_+__Channel_Blockade_by_Synthesis_and_Biological_Evaluation_of_Dofetilide_Analogues_</link><description>Guo D, Klaasse E, de Vries H, et al. <br/><span class="title">Exploring Chemical Substructures Essential for hERG K(+) Channel Blockade by Synthesis and Biological Evaluation of Dofetilide Analogues. [JOURNAL ARTICLE]</span><br/><span class="source" title="ChemMedChem">ChemMedChem 2009 Sep 1.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19725081/abstract/Exploring_Chemical_Substructures_Essential_for_hERG_K_+__Channel_Blockade_by_Synthesis_and_Biological_Evaluation_of_Dofetilide_Analogues_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19725081/full_citation/Exploring_Chemical_Substructures_Essential_for_hERG_K_+__Channel_Blockade_by_Synthesis_and_Biological_Evaluation_of_Dofetilide_Analogues_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19725081/Exploring_Chemical_Substructures_Essential_for_hERG_K_+__Channel_Blockade_by_Synthesis_and_Biological_Evaluation_of_Dofetilide_Analogues_">Find Related Articles</a> </description></item><item><title>Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19695388/full_citation/Initial_experience_with_antiarrhythmic_medication_monitoring_by_clinical_pharmacists_in_an_outpatient_setting:_a_retrospective_review_</link><description>Snider M, Kalbfleisch S, Carnes CA <br/><span class="title">Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review. [Journal Article]</span><br/><span class="source" title="Clinical therapeutics">Clin Ther 2009 Jun; 31(6):1209-18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19695388/abstract/Initial_experience_with_antiarrhythmic_medication_monitoring_by_clinical_pharmacists_in_an_outpatient_setting:_a_retrospective_review_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19695388/full_citation/Initial_experience_with_antiarrhythmic_medication_monitoring_by_clinical_pharmacists_in_an_outpatient_setting:_a_retrospective_review_">Full Citation</a></description></item><item><title>Dofetilide for Atrial Arrhythmias in Congenital Heart Disease: A Multicenter Study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19691680/full_citation/Dofetilide_for_Atrial_Arrhythmias_in_Congenital_Heart_Disease:_A_Multicenter_Study_</link><description>Wells R, Khairy P, Harris L, et al. <br/><span class="title">Dofetilide for Atrial Arrhythmias in Congenital Heart Disease: A Multicenter Study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pacing and clinical electrophysiology : PACE">Pacing Clin Electrophysiol 2009 Aug 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19691680/abstract/Dofetilide_for_Atrial_Arrhythmias_in_Congenital_Heart_Disease:_A_Multicenter_Study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19691680/full_citation/Dofetilide_for_Atrial_Arrhythmias_in_Congenital_Heart_Disease:_A_Multicenter_Study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19691680/Dofetilide_for_Atrial_Arrhythmias_in_Congenital_Heart_Disease:_A_Multicenter_Study_">Find Related Articles</a> </description></item><item><title>Dronedarone: A Promising Alternative for the Management of Atrial Fibrillation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19669399/full_citation/Dronedarone:_A_Promising_Alternative_for_the_Management_of_Atrial_Fibrillation_</link><description>Yalta K, Turgut OO, Yılmaz MB, et al. <br/><span class="title">Dronedarone: A Promising Alternative for the Management of Atrial Fibrillation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy">Cardiovasc Drugs Ther 2009 Aug 8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19669399/abstract/Dronedarone:_A_Promising_Alternative_for_the_Management_of_Atrial_Fibrillation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19669399/full_citation/Dronedarone:_A_Promising_Alternative_for_the_Management_of_Atrial_Fibrillation_">Full Citation</a></description></item><item><title>Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19663882/full_citation/Dog_left_ventricular_midmyocardial_myocytes_for_assessment_of_drug_induced_delayed_repolarization:_short_term_variability_and_proarrhythmic_potential_</link><description>Abi-Gerges N, Valentin JP, Pollard CE <br/><span class="title">Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Aug 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19663882/abstract/Dog_left_ventricular_midmyocardial_myocytes_for_assessment_of_drug_induced_delayed_repolarization:_short_term_variability_and_proarrhythmic_potential_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19663882/full_citation/Dog_left_ventricular_midmyocardial_myocytes_for_assessment_of_drug_induced_delayed_repolarization:_short_term_variability_and_proarrhythmic_potential_">Full Citation</a></description></item><item><title>Reverse rate dependency is an intrinsic property of canine cardiac preparations.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19556280/full_citation/Reverse_rate_dependency_is_an_intrinsic_property_of_canine_cardiac_preparations_</link><description>Bányász T, Horváth B, Virág L, et al. <br/><span class="title">Reverse rate dependency is an intrinsic property of canine cardiac preparations. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cardiovascular research">Cardiovasc Res 2009 Jun 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19556280/abstract/Reverse_rate_dependency_is_an_intrinsic_property_of_canine_cardiac_preparations_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19556280/full_citation/Reverse_rate_dependency_is_an_intrinsic_property_of_canine_cardiac_preparations_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19556280/Reverse_rate_dependency_is_an_intrinsic_property_of_canine_cardiac_preparations_">Find Related Articles</a> </description></item></channel></rss>